ADOC — Adocia SA Share News
0.000.00%
Last trade - 00:00- €51.42m
- €49.35m
- €1.48m
Brief: Adocia H1 Operating Income EUR -7.947 Million
Brief: Adocia Says Sanofi’S Exclusive Right For Partnership Agreement For Development Of M1Pram Has Expired
Brief: Adocia And Vester Finance Sign Shareholder Loan Agreement
Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides
Brief: Adocia H1 Operating Income EUR -8.932 Million
Brief: Adocia, Tonghua Dongbao Reports Positive Phase 3 Results For Ultra-Rapid Insulin In T2D
Brief: Adocia And Tonghua Dongbao Announce Final Dosing In Phase 3 Clinical Study Of Biochaperone® Lispro
Brief: Adocia Announces Appointment Of Mathieu‑William Gilbert As CFO
Health Rounds: Once-weekly insulin from Eli Lilly appears effective as daily injections
Brief: Adocia Appoints Mathieu‑William Gilbert As Chief Operating Officer
Brief: Adocia End-March Cash Position EUR 10.2 Million
Brief: Adocia End-December Cash Of EUR 13.0 mln
Brief: Adocia End-2023 Net Cash Position At 13.0 Million Euros
Brief: Adocia Q3 Revenue Down At Eur 320,000
Brief: Tonghua Dongbao Announces Positive Results In BioChaperone Trials
Brief: Adocia H1 Net Result Turns To Loss Of EUR 9.4 Million
Brief: Adocia Recieves EUR 500.000 In Proceeds From Partial Exercise Of Warrants Held By IPF Partners
Brief: Adocia Q2 Revenue Falls To EUR 815.000
Brief: Adocia Announces Q2 2023 Financial Results And A €10 Million Financing Operation